Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency

PHASE2CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

March 31, 2010

Conditions
AlcoholismAlcohol Abuse
Interventions
DRUG

Quetiapine fumarate

Quetiapine fumarate- taken daily, for 12 weeks

OTHER

Placebo

Placebo

Trial Locations (7)

12906

Brown University Center for Alcohol and Addiction Studies, Providence

19104

University of Pennsylvania, Treatment Research Center, Philadelphia

22908

University of Virginia, Dept. of Psychiatric Medicine, Charlottesville

23294

University of Virginia, Richmond

02118

Boston University School of Medicine, Psychiatry Clinical Studies Unit, Boston

03755

Dartmouth Medical School, Dept. of Psychiatry, Lebanon

05009

White River Junction VA Medical Center, White River Junction

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

AstraZeneca

INDUSTRY

collaborator

US Department of Veterans Affairs

FED

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH